No Data
No Data
Here's Why You Should Add OMCL Stock to Your Portfolio Now
Needham Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $112
Strategic Investment and Growth Potential Drive Buy Rating for Haemonetics
Haemonetics Management to Meet Virtually With BTIG
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
No Data
No Data